News >

Education, Collaboration Key to Increasing Genetic Screening in Prostate Cancer

Jessica Hergert
Published: Wednesday, Feb 05, 2020

Thomas J. Polascik, MD, a urologic oncologist at Duke University

Thomas J. Polascik, MD

With the advent of targeted therapy, understanding the genetic components of a patient's disease has become critical in oncology. As the role of genetic testing in prostate cancer has grown, the field is also overcoming hurdles with making it more widespread, said Thomas J. Polascik, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication